{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:19:08Z","timestamp":1783448348627,"version":"3.55.0"},"reference-count":27,"publisher":"Bioscientifica","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":165,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Primary adrenal insufficiency (PAI) in children, most commonly caused by congenital adrenal hyperplasia (CAH), is challenging to treat due to the short half-life of hydrocortisone and the difficulty in mimicking the physiological rhythm of cortisol. Continuous subcutaneous hydrocortisone infusion (CSHI) has shown benefits in CAH adults but remains poorly studied in children. The aim of our study was to evaluate the feasibility, safety, and clinical efficacy of CSHI in pediatric patients under oral treatment with poorly controlled PAI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective monocentric study including 13 children and adolescents with PAI who were switched from oral hydrocortisone to CSHI between 2017 and 2024 due to a lack of disease control. Hormonal and clinical parameters were monitored over a median follow-up of 48 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The median age at CSHI initiation was 11.08 (7.75\u201314.08) years. Eleven patients (84.6%) had CAH. The median duration of CSHI was 48 (6\u201354) months. Biochemical control improved, morning cortisol increased, while ACTH, 17-OHP, androstenedione, and testosterone levels decreased during follow-up. Growth velocity and BMI remained stable. In one patient with prior and recurrent adrenal crises, these events ceased. In boys with testicular adrenal rest tumors, tumor volume decreased or resolved. One adolescent girl with amenorrhea resumed regular menstrual cycles under CSHI. CSHI was well tolerated with no major complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CSHI offers a promising therapeutic alternative for children with PAI who are poorly controlled on oral therapy. It provides more physiological cortisol delivery, improves hormonal control, and appears safe during long-term pediatric use. Larger prospective studies are needed to confirm these findings and evaluate quality-of-life outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/ec-25-0696","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T12:28:43Z","timestamp":1767702523000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-10","source":"Crossref","is-referenced-by-count":1,"title":["Continuous subcutaneous hydrocortisone infusion in pediatric primary adrenal insufficiency: a cohort study"],"prefix":"10.1530","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8794-4138","authenticated-orcid":true,"given":"Khadidja","family":"Fouatih","sequence":"first","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Agathe","family":"Trouvin","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4232-3882","authenticated-orcid":true,"given":"Anne-Sophie","family":"Lambert","sequence":"additional","affiliation":[{"name":"1"},{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anya","family":"Rothenbuhler","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Verdelet","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Lise","family":"Lecoq","sequence":"additional","affiliation":[{"name":"2"},{"name":"3"},{"name":"4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Bouligand","sequence":"additional","affiliation":[{"name":"2"},{"name":"5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilia","family":"Laddada","sequence":"additional","affiliation":[{"name":"5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Chappell","sequence":"additional","affiliation":[{"name":"2"},{"name":"5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Lopez","sequence":"additional","affiliation":[{"name":"5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Bouyacoub","sequence":"additional","affiliation":[{"name":"6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azza","family":"Yahia","sequence":"additional","affiliation":[{"name":"6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazar","family":"Haidar","sequence":"additional","affiliation":[{"name":"6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Trabado","sequence":"additional","affiliation":[{"name":"2"},{"name":"6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Linglart","sequence":"additional","affiliation":[{"name":"1"},{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Bouvattier","sequence":"additional","affiliation":[{"name":"1"},{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6432-1098","authenticated-orcid":false,"given":"Abd El Kader","family":"Ait Tayeb","sequence":"additional","affiliation":[{"name":"2"},{"name":"3"},{"name":"5"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"key":"2026070714074783700_bib1","volume-title":"Endotext","author":"Kilberg","year":"2000"},{"key":"2026070714074783700_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2147\/TCRM.S294065","article-title":"Pediatric adrenal insufficiency: challenges and solutions","volume":"18","author":"Nistic\u00f2","year":"2022","journal-title":"Ther Clin Risk Manag"},{"key":"2026070714074783700_bib3","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1210\/jc.2009-2631","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline","volume":"95","author":"Speiser","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714074783700_bib4","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1210\/jc.2012-2102","article-title":"Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia","volume":"97","author":"Finkielstain","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714074783700_bib5","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1210\/jc.2013-1440","article-title":"Approach to the patient: the adult with congenital adrenal hyperplasia","volume":"98","author":"Auchus","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714074783700_bib6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1055\/s-0042-123037","article-title":"Long-term consequences of congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency in adolescents and adults","volume":"125","author":"Kim","year":"2017","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2026070714074783700_bib7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2265.2004.02106.x","article-title":"Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency","volume":"61","author":"Mah","year":"2004","journal-title":"Clin Endocrinol"},{"key":"2026070714074783700_bib8","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1210\/jc.2016-1916","article-title":"A phase 2 study of continuous subcutaneous hydrocortisone infusion in adults with congenital adrenal hyperplasia","volume":"101","author":"Nella","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714074783700_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2023\/5315059","article-title":"Patients with hypocortisolism treated with continuous subcutaneous hydrocortisone infusion (CSHI): an option for poorly controlled patients","volume":"2023","author":"Mortensen","year":"2023","journal-title":"Int J Endocrinol"},{"key":"2026070714074783700_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1530\/EJE-07-0052","article-title":"Continuous subcutaneous hydrocortisone infusion in Addison\u2019s disease","volume":"157","author":"L\u00f8v\u00e5s","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"2026070714074783700_bib11","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.eprac.2025.05.004","article-title":"Continuous subcutaneous hydrocortisone infusion in adrenal insufficiency: practical experience in 33 subjects","volume":"31","author":"Lee","year":"2025","journal-title":"Endocr Pract"},{"key":"2026070714074783700_bib12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/cen.12670","article-title":"Circadian hormone profiles and insulin sensitivity in patients with Addison\u2019s disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy","volume":"83","author":"Bj\u00f6rnsdottir","year":"2015","journal-title":"Clin Endocrinol"},{"key":"2026070714074783700_bib13","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1210\/jc.2009-0630","article-title":"Management of altered hydrocortisone pharmacokinetics in a boy with congenital adrenal hyperplasia using a continuous subcutaneous hydrocortisone infusion","volume":"94","author":"Bryan","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714074783700_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13633-016-0031-9","article-title":"Growth and descent of the testes in infants with hypogonadotropic hypogonadism receiving subcutaneous gonadotropin infusion","volume":"2016","author":"Lambert","year":"2016","journal-title":"Int J Pediatr Endocrinol"},{"key":"2026070714074783700_bib15","doi-asserted-by":"crossref","DOI":"10.1530\/EC-24-0082","article-title":"Early adolescence assessment of eleven boys treated with continuous subcutaneous infusion of recombinant LH and FSH during infancy","volume":"14","author":"Lambert","year":"2025","journal-title":"Endocr Connect"},{"key":"2026070714074783700_bib16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000479867","article-title":"Continuous subcutaneous recombinant parathyroid hormone (1\u201334) infusion in the management of childhood hypoparathyroidism associated with malabsorption","volume":"89","author":"Saraff","year":"2018","journal-title":"Horm Res Paediatr"},{"key":"2026070714074783700_bib17","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1210\/jc.2011-1359","article-title":"Long-term results of continuous subcutaneous recombinant PTH (1\u201334) infusion in children with refractory hypoparathyroidism","volume":"96","author":"Linglart","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714074783700_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s40618-022-01889-1","article-title":"Renin and electrolytes indicate the mineralocorticoid activity of fludrocortisone: a 6 year study in primary adrenal insufficiency","volume":"46","author":"Ceccato","year":"2022","journal-title":"J Endocrinol Investig"},{"key":"2026070714074783700_bib19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1046\/j.1365-2265.1997.1340955.x","article-title":"An assessment of optimal hydrocortisone replacement therapy","volume":"46","author":"Howlett","year":"1997","journal-title":"Clin Endocrinol"},{"key":"2026070714074783700_bib20","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1530\/EJE-08-0874","article-title":"Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy","volume":"160","author":"Debono","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"2026070714074783700_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.metabol.2017.02.005","article-title":"Pharmacokinetics of oral hydrocortisone \u2013 results and implications from a randomized controlled trial","volume":"71","author":"Werumeus Buning","year":"2017","journal-title":"Metabolism"},{"key":"2026070714074783700_bib22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/cen.13813","article-title":"Long-term use of continuous subcutaneous hydrocortisone infusion therapy in patients with congenital adrenal hyperplasia","volume":"89","author":"Mallappa","year":"2018","journal-title":"Clin Endocrinol"},{"key":"2026070714074783700_bib23","first-page":"e22","article-title":"Effect of medication dosing frequency on adherence in chronic diseases","volume":"15","author":"Saini","year":"2009","journal-title":"Am J Manag Care"},{"key":"2026070714074783700_bib24","first-page":"527","article-title":"Dosing frequency and medication adherence in chronic disease","volume":"18","author":"Coleman","year":"2012","journal-title":"J Manag Care Pharm"},{"key":"2026070714074783700_bib25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/cen.13490","article-title":"Decrease in salivary cortisol levels after glucocorticoid dose reduction in patients with adrenal insufficiency: a prospective proof-of-concept study","volume":"88","author":"Ceccato","year":"2018","journal-title":"Clin Endocrinol"},{"key":"2026070714074783700_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5402\/2011\/219494","article-title":"Results of the prolonged use of subcutaneous continuous infusion of hydrocortisone in a man with congenital adrenal hyperplasia","volume":"2011","author":"Sonnet","year":"2011","journal-title":"ISRN Endocrinol"},{"key":"2026070714074783700_bib27","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1210\/jcem.86.6.7522","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: alterations in cortisol pharmacokinetics at puberty","volume":"86","author":"Charmandari","year":"2001","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Endocrine Connections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ec.bioscientifica.com\/view\/journals\/ec\/15\/1\/EC-25-0696.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/15\/1\/EC-25-0696.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-25-0696\/505006\/ec-25-0696.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-25-0696\/505006\/ec-25-0696.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:07:56Z","timestamp":1783447676000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article\/15\/1\/e250696\/75872\/Continuous-subcutaneous-hydrocortisone-infusion-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.1530\/ec-25-0696","relation":{},"ISSN":["2049-3614"],"issn-type":[{"value":"2049-3614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,1]]},"article-number":"e250696"}}